Clinical and Peripheral Blood Markers Predict Relapsed/Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant. GMSJ [Internet]. 2025 Dec. 27 [cited 2026 Aug. 24];1(S1). Available from: http://gmscholars.com/index.php/gmsj/article/view/59